Renal Cell Carcinoma | Consensus or Controversy? Clinical Investigators Discuss the Optimal Management of Metastatic Renal Cell Carcinoma

published 5 months ago by Dr Neil Love

Proceedings from a CME symposium held at the 2020 Genitourinary Cancers Symposium. Featuring perspectives from Dr Toni K Choueiri, Dr Thomas E Hutson, Dr David F McDermott and Prof Thomas Powles. Introduction Program Overview: Dr Neil Love (00:00) Optimizing Front-Line Decision-Making for Advanced Renal Cell Carcinoma (RCC) Roundtable Discussion (0:34) Faculty Presentation — Prof Powles (23:01) Selection and Sequencing of Therapy for Patients with Relapsed/Refractory RCC Roundtable Discussion (37:02) Faculty Presentation — Dr Choueiri (46:49) Novel Strategies Under Investigation in RCC Roundtable Discussion (1:00:09) Faculty Presentation — Dr Hutson (1:13:29) Identification and Management of Adverse Events Associated with Immune Checkpoint Inhibitor and TKI Therapy Roundtable Discussion (1:25:45) Faculty Presentation — Dr McDermott (1:34:03) CME information and select publications

more episodes from Research To Practice | Oncology Videos